
Metaxalone (400mg) + Diclofenac (50mg)
Active composition
+1 more active ingredient
Metaxalone depresses the central nervous system, leading to muscle relaxation and reduced muscle spasms.
Diclofenac inhibits COX-1 and COX-2 enzymes, leading to decreased synthesis of prostaglandins, which mediate pain and inflammation.
Medical applications
Mobiswift-D Tablet is a fixed-dose combination product containing 50mg of diclofenac, a non-steroidal anti-inflammatory agent, and 400mg of metaxalone, a muscle relaxant. It is indicated for the relief of moderate to severe acute pain and muscle spasms, particularly in the treatment of post-operative pain, dental pain, and menstrual cramps. The diclofenac component provides potent anti-inflammatory and analgesic effects, while the metaxalone component relaxes muscle spasms and reduces muscle tone. The combination of these two agents offers a synergistic effect, providing rapid and effective relief from pain and discomfort. The tablet is administered orally, typically 3-4 times a day, with or without food, and should be taken as directed by a healthcare provider. The recommended duration of treatment is up to 7 days, unless otherwise directed. As with all medications, Mobiswift-D Tablet should be used with caution in patients with a history of gastrointestinal ulcers, bleeding, or kidney disease, and should not be used in patients with a known hypersensitivity to either component.
How to use Mobiswift-D Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mobiswift-D Tablet is to be taken empty stomach.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Mobiswift-D Tablet.
High Risk
Mobiswift-D Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Medical Advice
Mobiswift-D Tablet may cause side effects which could affect your ability to drive.
Exercise Caution
Mobiswift-D Tablet should be used with caution in patients with liver disease. Dose adjustment of Mobiswift-D Tablet may be needed. Please consult your doctor. Regular monitoring of liver function tests is recommended in patients with liver disease if this medicine is to be taken for a long time.
Regular Checkup
Mobiswift-D Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Mobiswift-D Tablet should be used with caution in patients with kidney disease. Dose adjustment of Mobiswift-D Tablet may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Mobiswift-D Tablet

Diclofenac (50mg) + Metaxalone (400mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Metaxalone depresses the central nervous system, leading to muscle relaxation and reduced muscle spasms.
Diclofenac inhibits COX-1 and COX-2 enzymes, leading to decreased synthesis of prostaglandins, which mediate pain and inflammation.
Medical applications
Mobiswift-D Tablet is a fixed-dose combination product containing 50mg of diclofenac, a non-steroidal anti-inflammatory agent, and 400mg of metaxalone, a muscle relaxant. It is indicated for the relief of moderate to severe acute pain and muscle spasms, particularly in the treatment of post-operative pain, dental pain, and menstrual cramps. The diclofenac component provides potent anti-inflammatory and analgesic effects, while the metaxalone component relaxes muscle spasms and reduces muscle tone. The combination of these two agents offers a synergistic effect, providing rapid and effective relief from pain and discomfort. The tablet is administered orally, typically 3-4 times a day, with or without food, and should be taken as directed by a healthcare provider. The recommended duration of treatment is up to 7 days, unless otherwise directed. As with all medications, Mobiswift-D Tablet should be used with caution in patients with a history of gastrointestinal ulcers, bleeding, or kidney disease, and should not be used in patients with a known hypersensitivity to either component.
How to use Mobiswift-D Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mobiswift-D Tablet is to be taken empty stomach.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Mobiswift-D Tablet.
High Risk
Mobiswift-D Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Medical Advice
Mobiswift-D Tablet may cause side effects which could affect your ability to drive.
Exercise Caution
Mobiswift-D Tablet should be used with caution in patients with liver disease. Dose adjustment of Mobiswift-D Tablet may be needed. Please consult your doctor. Regular monitoring of liver function tests is recommended in patients with liver disease if this medicine is to be taken for a long time.
Regular Checkup
Mobiswift-D Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Mobiswift-D Tablet should be used with caution in patients with kidney disease. Dose adjustment of Mobiswift-D Tablet may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Mobiswift-D Tablet











